Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

BARBARA ANN KARMANOS CANCER HOSPITAL

NPI: 1316900277 · DETROIT, MI 48201 · General Acute Care Hospital · NPI assigned 04/10/2006

$42.45M
Total Medicaid Paid
547,347
Total Claims
387,667
Beneficiaries
236
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialDOXTADER, REGINA (CFO)
NPI Enumeration Date04/10/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 74,359 $7.79M
2019 80,196 $5.84M
2020 72,046 $5.22M
2021 79,360 $5.62M
2022 78,158 $5.64M
2023 91,381 $6.45M
2024 71,847 $5.88M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
J9271 Injection, pembrolizumab, 1 mg 2,263 1,801 $13.36M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 69,653 52,644 $4.46M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 17,319 10,400 $2.86M
77386 7,228 648 $1.98M
78815 Positron emission tomography (PET) for limited area imaging 2,493 2,473 $1.92M
J9299 Injection, nivolumab, 1 mg 370 259 $1.79M
77412 12,115 1,370 $1.49M
J9355 Injection, trastuzumab, excludes biosimilar, 10 mg 560 329 $1.13M
77067 Screening mammography, bilateral, including computer-aided detection 18,672 18,601 $912K
74177 Computed tomography, abdomen and pelvis; with contrast material 4,881 4,824 $881K
J2505 Injection, pegfilgrastim, 6 mg 374 296 $826K
19083 1,013 985 $774K
77334 2,140 1,705 $663K
J9035 Injection, bevacizumab, 10 mg 290 161 $645K
Q5111 Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg 313 239 $608K
96375 Therapeutic injection; each additional sequential IV push 12,299 7,162 $491K
71260 Computed tomography, thorax, diagnostic; with contrast material 6,266 6,192 $394K
77336 5,490 2,433 $359K
77300 1,615 1,514 $314K
P9016 Red blood cells, leukocytes reduced, each unit 532 419 $270K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 1,376 1,353 $269K
77295 429 381 $247K
J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg 345 269 $236K
36512 400 299 $235K
96417 5,852 3,975 $227K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2,600 1,735 $222K
70491 1,535 1,517 $212K
Q5117 Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg 129 89 $198K
76642 7,101 6,054 $196K
77066 Tomosynthesis, mammo 3,266 3,210 $191K
J9070 Cyclophosphamide, 100 mg 906 463 $189K
36430 1,002 570 $188K
77065 Tomosynthesis, mammo 3,890 3,586 $173K
J0185 Injection, aprepitant, 1 mg 1,253 903 $155K
31575 1,886 1,827 $148K
96415 2,853 2,036 $140K
80053 Comprehensive metabolic panel 35,178 23,708 $140K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1,549 1,240 $136K
G0379 Direct admission of patient for hospital observation care 120 112 $131K
96361 Intravenous infusion, hydration; each additional hour 3,821 1,952 $127K
96416 841 508 $124K
96367 3,425 2,523 $122K
78306 647 646 $122K
36556 259 188 $121K
77063 Screening digital breast tomosynthesis, bilateral 8,584 8,583 $119K
J1950 Injection, leuprolide acetate (for depot suspension), per 3.75 mg 123 118 $117K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 38,105 24,946 $112K
77290 550 497 $89K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 884 524 $88K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 4,507 3,149 $78K
36561 57 54 $73K
77338 392 366 $68K
96411 1,700 1,188 $65K
72197 216 216 $58K
77301 85 81 $56K
88307 396 388 $55K
77385 237 12 $55K
J0897 Injection, denosumab, 1 mg 41 38 $53K
J9217 Leuprolide acetate (for depot suspension), 7.5 mg 148 145 $49K
88305 Level IV - Surgical pathology, gross and microscopic examination 3,311 3,208 $48K
J9306 Injection, pertuzumab, 1 mg 22 12 $48K
88341 759 741 $47K
84443 Thyroid stimulating hormone (TSH) 6,588 5,762 $45K
Q5107 Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg 51 24 $43K
Q3014 Telehealth originating site facility fee 2,422 2,303 $39K
71250 641 637 $36K
96402 2,062 1,966 $35K
83735 11,346 6,605 $30K
78816 37 37 $29K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 516 492 $26K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1,132 773 $24K
86300 3,004 1,329 $24K
82784 3,110 2,503 $22K
71046 Radiologic examination, chest; 2 views 553 539 $20K
88342 815 800 $20K
77280 282 250 $19K
83615 8,396 6,044 $19K
86900 5,177 3,620 $18K
82378 2,199 1,918 $16K
84153 2,276 2,112 $16K
86850 4,850 3,368 $16K
83521 1,129 1,024 $15K
86334 1,672 1,532 $14K
J1453 Injection, fosaprepitant, 1 mg 294 217 $14K
J9045 Injection, carboplatin, 50 mg 2,209 1,464 $14K
86304 1,345 1,153 $12K
80048 Basic metabolic panel (calcium, ionized) 3,188 2,170 $10K
76536 256 253 $10K
J9171 Injection, docetaxel, 1 mg 271 135 $9K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 281 268 $9K
84165 1,985 1,810 $9K
38505 12 12 $8K
C8908 Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral 41 41 $8K
84439 2,005 1,875 $8K
J2405 Injection, ondansetron hydrochloride, per 1 mg 10,555 6,809 $7K
J9267 Injection, paclitaxel, 1 mg 2,636 1,167 $7K
76641 276 199 $7K
96409 73 50 $7K
87496 582 249 $6K
82728 1,014 851 $6K
82565 3,022 2,963 $6K
84100 2,722 1,778 $6K
84703 1,747 1,466 $5K
86901 5,175 3,619 $5K
C9463 Injection, aprepitant, 1 mg 45 27 $5K
84403 474 441 $5K
86301 570 496 $5K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 350 340 $5K
74183 39 39 $5K
J3489 Injection, zoledronic acid, 1 mg 395 369 $5K
85610 2,789 2,449 $4K
77080 77 77 $4K
87086 Culture, bacterial; quantitative colony count, urine 1,137 1,035 $3K
G0378 Hospital observation service, per hour 257 225 $3K
94726 129 128 $3K
82607 390 376 $3K
83540 462 451 $3K
85730 1,358 1,163 $3K
96401 172 74 $3K
78472 16 15 $3K
J1750 Injection, iron dextran, 50 mg 21 12 $3K
84702 334 275 $2K
84550 1,031 635 $2K
36415 Collection of venous blood by venipuncture 14,781 11,957 $2K
85027 932 737 $2K
86923 212 156 $2K
86769 57 56 $1K
94060 14 14 $1K
85046 508 381 $1K
81001 1,021 926 $1K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision 108 108 $1K
J9000 Injection, doxorubicin hydrochloride, 10 mg 303 177 $1K
82746 147 146 $1K
90671 12 12 $933.94
87305 322 147 $885.07
36591 63 59 $830.30
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 12 12 $780.68
76830 Ultrasound, transvaginal 12 12 $780.68
90472 Immunization administration, each additional vaccine (list separately) 12 12 $776.82
87625 40 39 $614.60
74160 43 40 $566.69
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 42 41 $515.05
82533 50 40 $505.54
86800 61 61 $487.72
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 340 278 $468.35
82570 167 138 $445.28
94760 623 488 $441.18
86706 109 108 $437.78
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 13 13 $424.60
81003 401 387 $356.94
J9263 Injection, oxaliplatin, 0.5 mg 529 239 $344.98
84432 26 26 $225.39
36592 41 37 $194.37
77062 1,576 1,574 $190.40
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 12 12 $183.73
84295 240 231 $175.99
84132 250 239 $170.04
83036 Hemoglobin; glycosylated (A1C) 28 28 $156.03
87799 17 13 $150.04
86140 72 39 $143.43
J2704 Injection, propofol, 10 mg 3,279 3,046 $128.69
84481 12 12 $100.27
85014 274 263 $99.03
84156 59 48 $97.22
J3490 Unclassified drugs 24,765 8,744 $93.35
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 21 21 $76.68
77061 899 897 $74.10
84166 12 12 $72.69
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 7,324 4,517 $71.71
J8540 Dexamethasone, oral, 0.25 mg 4,915 2,718 $50.14
96549 640 394 $42.65
J2250 Injection, midazolam hydrochloride, per 1 mg 2,672 2,527 $28.27
88142 79 76 $24.14
81025 17 13 $22.56
96368 1,110 784 $21.69
J7050 Infusion, normal saline solution, 250 cc 6,724 4,179 $8.63
82330 56 51 $8.59
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg 557 372 $8.31
87070 13 12 $4.75
J1200 Injection, diphenhydramine hcl, up to 50 mg 6,515 3,926 $3.80
J1100 Injection, dexamethasone sodium phosphate, 1 mg 5,154 3,634 $3.33
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 5,237 3,269 $2.93
J0330 Injection, succinylcholine chloride, up to 20 mg 496 481 $0.94
J2270 Injection, morphine sulfate, up to 10 mg 687 572 $0.00
C1752 Catheter, hemodialysis/peritoneal, short-term 231 165 $0.00
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 2,510 2,494 $0.00
A4216 Sterile water, saline and/or dextrose, diluent/flush, 10 ml 307 198 $0.00
J7030 Infusion, normal saline solution , 1000 cc 3,797 2,143 $0.00
J9190 Injection, fluorouracil, 500 mg 971 471 $0.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 7,264 7,073 $0.00
J1644 Injection, heparin sodium, per 1000 units 1,252 759 $0.00
J0640 Injection, leucovorin calcium, per 50 mg 581 345 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 1,280 677 $0.00
S5000 Prescription drug, generic 1,808 1,026 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 541 450 $0.00
76937 910 785 $0.00
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg 24 12 $0.00
J1756 Injection, iron sucrose, 1 mg 319 169 $0.00
76942 27 26 $0.00
94729 131 130 $0.00
82542 105 66 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 12 12 $0.00
90713 12 12 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 27 25 $0.00
J1171 Injection, hydromorphone, 0.1 mg 40 36 $0.00
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg 17 13 $0.00
J2004 Injection, lidocaine hcl with epinephrine, 1 mg 37 37 $0.00
A4648 Tissue marker, implantable, any type, each 1,418 1,391 $0.00
C1769 Guide wire 788 681 $0.00
J3010 Injection, fentanyl citrate, 0.1 mg 2,923 2,674 $0.00
77417 534 326 $0.00
J0690 Injection, cefazolin sodium, 500 mg 1,243 861 $0.00
J3480 Injection, potassium chloride, per 2 meq 424 267 $0.00
J7060 5% dextrose/water (500 ml = 1 unit) 2,977 1,941 $0.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 1,257 668 $0.00
J1170 Injection, hydromorphone, up to 4 mg 712 511 $0.00
A9503 Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries 503 502 $0.00
J2060 Injection, lorazepam, 2 mg 204 135 $0.00
A9585 Injection, gadobutrol, 0.1 ml 1,295 1,258 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 203 85 $0.00
77001 354 290 $0.00
C1892 Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away 108 97 $0.00
83883 89 80 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 85 74 $0.00
J9074 Injection, cyclophosphamide (sandoz), 5 mg 18 12 $0.00
36410 14 14 $0.00
J0610 Injection, calcium gluconate (fresenius kabi), per 10 ml 362 232 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 27 26 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 13 12 $0.00
96376 83 57 $0.00
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml 50 47 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 25 24 $0.00
J9202 Goserelin acetate implant, per 3.6 mg 12 12 $0.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 16 12 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 22 12 $0.00
A9560 Technetium tc-99m labeled red blood cells, diagnostic, per study dose, up to 30 millicuries 13 12 $0.00